115 related articles for article (PubMed ID: 9690514)
1. Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts.
Salvat C; Jariel-Encontre I; Acquaviva C; Omura S; Piechaczyk M
Oncogene; 1998 Jul; 17(3):327-37. PubMed ID: 9690514
[TBL] [Abstract][Full Text] [Related]
2. Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition.
Acquaviva C; Brockly F; Ferrara P; Bossis G; Salvat C; Jariel-Encontre I; Piechaczyk M
Oncogene; 2001 Nov; 20(51):7563-72. PubMed ID: 11709728
[TBL] [Abstract][Full Text] [Related]
3. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
[TBL] [Abstract][Full Text] [Related]
4. Complex mechanisms for c-fos and c-jun degradation.
Jariel-Encontre I; Salvat C; Steff AM; Pariat M; Acquaviva C; Furstoss O; Piechaczyk M
Mol Biol Rep; 1997 Mar; 24(1-2):51-6. PubMed ID: 9228281
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes.
Hermida-Matsumoto ML; Chock PB; Curran T; Yang DC
J Biol Chem; 1996 Mar; 271(9):4930-6. PubMed ID: 8617766
[TBL] [Abstract][Full Text] [Related]
6. Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?
Salvat C; Aquaviva C; Jariel-Encontre I; Ferrara P; Pariat M; Steff AM; Carillo S; Piechaczyk M
Mol Biol Rep; 1999 Apr; 26(1-2):45-51. PubMed ID: 10363646
[TBL] [Abstract][Full Text] [Related]
7. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.
Stancovski I; Gonen H; Orian A; Schwartz AL; Ciechanover A
Mol Cell Biol; 1995 Dec; 15(12):7106-16. PubMed ID: 8524278
[TBL] [Abstract][Full Text] [Related]
8. Degradation of cellular and viral Fos proteins.
Acquaviva C; Ferrara P; Bossis G; Brockly F; Salvat C; Jariel-Encontre I; Piechaczyk M
Biochimie; 2001; 83(3-4):357-62. PubMed ID: 11295497
[TBL] [Abstract][Full Text] [Related]
9. Multiple degradation pathways for Fos family proteins.
Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
Ann N Y Acad Sci; 2002 Nov; 973():426-34. PubMed ID: 12485905
[TBL] [Abstract][Full Text] [Related]
10. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo.
Bossis G; Ferrara P; Acquaviva C; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2003 Oct; 23(20):7425-36. PubMed ID: 14517309
[TBL] [Abstract][Full Text] [Related]
11. Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins.
Kovary K; Bravo R
Mol Cell Biol; 1992 Nov; 12(11):5015-23. PubMed ID: 1406676
[TBL] [Abstract][Full Text] [Related]
12. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts.
Lallemand D; Spyrou G; Yaniv M; Pfarr CM
Oncogene; 1997 Feb; 14(7):819-30. PubMed ID: 9047389
[TBL] [Abstract][Full Text] [Related]
13. Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome.
Lafarga M; Berciano MT; Pena E; Mayo I; Castaño JG; Bohmann D; Rodrigues JP; Tavanez JP; Carmo-Fonseca M
Mol Biol Cell; 2002 Aug; 13(8):2771-82. PubMed ID: 12181345
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Requirements upon different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo.
Salvat C; Acquaviva C; Scheffner M; Robbins I; Piechaczyk M; Jariel-Encontre I
Eur J Biochem; 2000 Jun; 267(12):3712-22. PubMed ID: 10848989
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
Tay DL; Hoffbrand AV; Wickremasinghe GR
Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
[TBL] [Abstract][Full Text] [Related]
16. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
Vial E; Marshall CJ
J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways.
Agarwal S; Corbley MJ; Roberts TM
Oncogene; 1995 Aug; 11(3):427-38. PubMed ID: 7543194
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of FOS and JUN family members to calpains.
Carillo S; Pariat M; Steff AM; Roux P; Etienne-Julan M; Lorca T; Piechaczyk M
Oncogene; 1994 Jun; 9(6):1679-89. PubMed ID: 8183563
[TBL] [Abstract][Full Text] [Related]
19. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
Catling AD; Wyke JA; Frame MC
Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
[TBL] [Abstract][Full Text] [Related]
20. T-kininogen inhibits fibroblast proliferation in the G(1) phase of the cell cycle.
Torres C; Li M; Walter R; Sierra F
Exp Cell Res; 2001 Oct; 269(2):171-9. PubMed ID: 11570809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
